Harbor Capital Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,375
| Closed | -$142K | – | 740 |
|
|
2024
Q1 | $142K | Buy |
19,375
+3,844
| +25% | +$28.2K | 0.02% | 681 |
|
|
2023
Q4 | $58.1K | Buy |
15,531
+725
| +5% | +$2.71K | 0.01% | 430 |
|
|
2023
Q3 | $31.4K | Buy |
14,806
+2,678
| +22% | +$5.68K | 0.01% | 442 |
|
|
2023
Q2 | $57.7K | Buy |
12,128
+1,132
| +10% | +$5.39K | 0.01% | 481 |
|
|
2023
Q1 | $62.7K | Buy |
10,996
+82
| +0.8% | +$467 | 0.02% | 242 |
|
|
2022
Q4 | $110K | Sell |
10,914
-232
| -2% | -$2.34K | 0.11% | 84 |
|
|
2022
Q3 | $250K | Sell |
11,146
-306
| -3% | -$6.86K | 0.23% | 79 |
|
|
2022
Q2 | $284K | Sell |
11,452
-1,256
| -10% | -$31.1K | 0.22% | 77 |
|
|
2022
Q1 | $493K | Sell |
12,708
-1,869
| -13% | -$72.5K | 0.23% | 79 |
|
|
2021
Q4 | $853K | Buy |
+14,577
| New | +$853K | 0.31% | 79 |
|